Verve Therapeutics: Funding, Investors & Team (Oct 2026)
Verve Therapeutics is a biotech company that was founded by experts in cardiovascular medicine, genetics, and gene editing with the purpose of safeguarding the world against heart disease. Their primary goal is to create revolutionary treatments for coronary heart disease that only require a one-time administration. By utilizing gene editing techniques, Verve aims to safely modify the genetic makeup of adults, imitating natural gene variations to permanently decrease LDL cholesterol and triglyceride levels. The company is currently making progress on a range of tailored genetic therapies, led by VERVE-101, which is initially being developed for a life-threatening genetic heart condition known as heterozygous familial hypercholesterolemia. In 2022, Verve earned recognition from the Boston Globe as one of the "Best Places to Work." The company's headquarters are located in Boston, Massachusetts.
Verve Therapeutics has raised $279M across 3 funding rounds on record, the most recent an undisclosed round of $125M announced in Nov 2023.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Verve Therapeutics Company Profile and Key Stats
Latest funding round on record: Nov 2023.
Verve Therapeutics Funding Rounds
Verve Therapeutics raised $94.0M in a Series B announced in Jan 2021.
2.4 years later, an undisclosed round of $60.0M was announced in Jun 2023.
5 months later, an undisclosed round of $125M was announced in Nov 2023.
Verve Therapeutics Founders and Leadership Team
Contact details for the Verve Therapeutics team: 1 of 2 have an email address on file.
Start 14-day free trial →Verve Therapeutics Funding Compared to Other Biotechnology Startups
Verve Therapeutics' latest round of $125M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Verve Therapeutics in Biotechnology and Boston
Companies Similar to Verve Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Verve Therapeutics Funding FAQs
What does Verve Therapeutics do?
Verve Therapeutics is a biotech company that was founded by experts in cardiovascular medicine, genetics, and gene editing with the purpose of safeguarding the world against heart disease. Their primary goal is to create revolutionary treatments for coronary heart disease that only require a one-time administration. By utilizing gene editing techniques, Verve aims to safely modify the genetic makeup of adults, imitating natural gene variations to permanently decrease LDL cholesterol and triglyceride levels. The company is currently making progress on a range of tailored genetic therapies, led by VERVE-101, which is initially being developed for a life-threatening genetic heart condition known as heterozygous familial hypercholesterolemia. In 2022, Verve earned recognition from the Boston Globe as one of the "Best Places to Work." The company's headquarters are located in Boston, Massachusetts.
How much funding has Verve Therapeutics raised?
Verve Therapeutics has raised $279M across 3 rounds on record. The most recent is an undisclosed round of $125M announced in Nov 2023.
When did Verve Therapeutics last raise funding?
Verve Therapeutics' most recent funding round on record is an undisclosed round of $125M, announced in Nov 2023.
Who founded Verve Therapeutics?
FundedIQ lists Burt Adelman (Founder), Sekar Kathiresan (Founder) at Verve Therapeutics.
Where is Verve Therapeutics headquartered?
Verve Therapeutics is based in Boston, Massachusetts, United States.
How many employees does Verve Therapeutics have?
Verve Therapeutics is in the 251-500 employee band.
How does Verve Therapeutics' funding compare to other Biotechnology startups?
Verve Therapeutics' latest round of $125M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Verve Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Verve Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.